Related Experiment Video
Updated: Jun 10, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function
Kathleen C Prins1, Jennifer M Binning, Reed S Shabman
1Department of Microbiology, Mount Sinai School of Medicine, Box 1124, 1 Gustave L. Levy Place, New York, NY 10029, USA.
Ebolavirus VP35 protein
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- Ebolavirus (EBOV) VP35 protein is crucial for viral replication and immune evasion.
- VP35 binds double-stranded RNA (dsRNA) and inhibits host interferon (IFN) production.
- The C-terminal IFN inhibitory domain (IID) of VP35 has key structural features for dsRNA binding and IFN inhibition.
Purpose of the Study:
- To investigate the role of conserved basic residues in the EBOV VP35 C-terminal IID.
- To determine the function of these residues in dsRNA binding, IFN inhibition, and viral RNA synthesis.
- To elucidate the interaction of VP35 with nucleoprotein (NP) and its role in replication complex formation.
Main Methods:
- Alanine substitution mutagenesis of VP35.
- In vitro assays for dsRNA binding and IFN inhibition.
- Minigenome assays to assess viral RNA polymerase function.
- Coimmunoprecipitation assays to study protein-protein interactions (VP35-NP).
Main Results:
- Basic residues outside the central dsRNA-binding patch are not essential for dsRNA binding or IFN inhibition.
- These residues, particularly within the first basic patch, are critical for viral RNA synthesis.
- The first basic patch is important for VP35 interaction with NP, suggesting a role in replication complex formation.
- VP35 IID interacts with NP, and dsRNA binding can modulate this interaction.
Conclusions:
- Conserved basic residues in the EBOV VP35 C-terminal IID play distinct roles in viral functions.
- Specific basic residues are critical for replication complex assembly via NP interaction.
- The VP35 IID is a validated target for therapeutic intervention against Ebolavirus.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
09:38Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
Related Concept Videos
Leaky Scanning
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Inhibitors of Virion Maturation and Assembly
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...